Blockbuster Pharmaceutical Launches: Establishing Market Leadership (PH85) :

The blockbuster drug model drove the pharmaceutical industry to great heights for decades. In the current pharmaceutical market, however, blockbusters are becoming few and far between. In what can sometimes be a search for pharma's holy grail, the difference between discovering a blockbuster and the next me-too product often comes down to experience and expenditure.

Companies & Therapeutic Areas Included in Report

Companies

Abbott Laboratories
Amgen
AstraZeneca
Berlex

Therapeutic Areas

Cardiovascular
Central Nervous System
Depression
Endocrinology

Charts & Graphics table of contents :

RESOURCE ALLOCATION AND STRATEGIC PROFILES
Figure E.1: Study Context: Therapeutic Areas
Figure E.2: Niche Brand Commercialization Spending Breakdown
Figure E.3: Percent of Marketing Budget by Phase

GLOBAL RESOURCE ALLOCATION


Figure 1.1: Mid-Level Brand Global Expenditures and Sales

Table 1.1: Global Launch Context
Figure 1.2: Global Spending
Figure 1.3: Global Staffing
Figure 1.4: Global Activities Spending
Figure 1.5: Global Activities Staffing

EUROPEAN MARKETING


Figure 2.1: European Marketing Mix

Table 2.1: European Launch Context
Figure 2.2: European Total Spending
Figure 2.3: European Total Staffing
Figure 2.4: European Brand Activities Spending
Figure 2.5: European Brand Activities Staffing

US COMMERCIALIZATION

Figure 3.1: US Marketing Mix
Table 3.1: US Launch Context
Figure 3.2: US Total Spending
Figure 3.3: US Total Staffing
Figure 3.4: US Brand Activities Spending
Figure 3.5: US Brand Activities Staffing

for more information, please visit our web site :
http://www.bharatbook.com/detail.asp?id=52020